Drugmaker Eli Lilly announced today that it will cap the cost of insulin at $35 a month, bringing costs for people with private insurance and those without insurance who sign up for Lilly’s copay assistance program into line with the $35 cap for Medicare recipients Congress imposed with the Inflation Reduction Act last August.
Read other posts